Pharmaceutical cancer research is a multi-billion euro industry that promises patients longer and more pain-free lives. But how reliable are the new drugs? Do their benefits outweigh any potential harms? Who actually controls their usage in practice?
A new documentary seeks to uncover the truth behind this booming industry. With more and more fast-tracked drugs flooding the market and less certainty about their actual benefits, the documentary challenges the hype surrounding the latest breakthrough therapies. Expert voices, including Prof. Wolf-Dieter Ludwig, Chairman of the German Medical Association’s Drug Commission, weigh in on whether or not the money poured into this field is truly leading to the increased survival rates that cancer patients so desperately need. Don’t miss this eye-opening look at the realities of pharmaceutical cancer research.